GPLD1 and Alzheimer disease: This is in line with previous results showing that Aβ leads to increased total PLD activity and that PLD2 genetic ablation ameliorates synaptic and behavioral deficits in an amyloidogenesis AD mouse model, independently of an effect on APP processing5.